Value of an aggregate index in describing the impact of trends in antimicrobial resistance for Escherichia coli

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 26, Issue 1, 2015, Pages 33-38

  Patrick, David M ^a   Chambers, Catharine ^a   Purych, Dale ^b,c   Chong, Mei ^a   George, Diana ^a   Marra, Fawziah ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b LifeLabs Medical Laboratory Services   (Canada)

^c FRASER HEALTH AUTHORITY   (Canada)

Author keywords

Antimicrobial resistance; Drug resistance index; Escherichia coli

Indexed keywords

AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; NITROFURAN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG RESISTANCE INDEX; DRUG USE; ESCHERICHIA COLI; FEMALE; GENDER; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OUTPATIENT; PRESCRIPTION; URINARY TRACT INFECTION;

EID: 84923266870     PISSN: 17129532     EISSN: 19181493     Source Type: Journal    
DOI: 10.1155/2015/274298     Document Type: Article

References (33)

1. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010;7:653-60.
2. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008;35:1-12.
3. Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. Am J Med 2002;113(Suppl 1A):14S-9S.
4. Blondel-Hill E, Fryters S. Bugs and Drugs: An Antimicrobial/Infectious Disease Reference, 2012 edn. Edmonton: Alberta Health Services, 2012.
5. Cohen ML. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science 1992;257:1050-5.
6. Kunin CM. Resistance to antimicrobial drugs - a worldwide calamity. Ann Intern Med 1993;118:557-61.
7. Karlowsky JA, Lagace-Wiens PR, Simner PJ, et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob Agents Chemother 2011;55:3169-75.
8. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2005;26:380-8.
9. Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.
10. British Columbia Centre for Disease Control. Antimicrobial resistance trends in the province of British Columbia, 2011. Vancouver: Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, 2012.
11. Ben Ami R, Rodriguez-Bano J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009;49:682-90.
12. Colodner R, Rock W, Chazan B, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 2004;23:163-7.
13. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 2008;36:41-5.
14. Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: A prospective study. J Clin Microbiol 2001;39:438-44.
15. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999;14:606-9.
16. Laxminarayan R, Klugman KP. Communicating trends in resistance using a drug resistance index. BMJ Open 2011;1:e000135.
17. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2012. Oslo: World Health Organization, 2011.
18. American Medical Association. International Classification of Diseases, 9th Revision, Clinical Modification. 1997.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th information supplement. CLSI document M100-S19. Wayne: Clinical and Laboratory Standards Institute, 2009.
20. BC Stats. Population projections. (Accessed January 9, 2013).
21. Magiorakos A P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
22. Gupta K. Addressing antibiotic resistance. Am J Med 2002;113(Suppl 1A):29S-34S.
23. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61:273-81.
24. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9.
25. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-e120.
26. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-63.
27. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for empiric therapy. Eur Urol 2008;54:1164-75.
28. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med 2002;113(Suppl 1A):1S-4S.
29. Ma JF, Shortliffe LM. Urinary tract infection in children: Etiology and epidemiology. Urol Clin North Am 2004;31:517-26.
30. Neal DE, Jr. Complicated urinary tract infections. Urol Clin North Am 2008;35:13-22.
31. Nicolle LE. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005;16:349-60.
32. Fuertes EI, Henry B, Marra F, Wong H, Patrick DM. Trends in antibiotic utilization in Vancouver associated with a community education program on antibiotic use. Can J Public Health 2010;101:304-8.
33. McKay RM, Vrbova L, Fuertes E, et al. Evaluation of the Do Bugs Need Drugs? program in British Columbia: Can we curb antibiotic prescribing? Can J Infect Dis Med Microbiol 2011;22:19-24.